Liposome encapsulation reduces cantharidin toxicity

Food and Chemical Toxicology

Volumn 46, Issue 9, 2008, Pages 3116-3121

  Chang, Chun Chao ^a   Liu, Der Zen ^b   Lin, Shyr Yi ^a   Liang, Hong Jen ^c   Hou, Wen Chi ^b   Huang, Wei Jan ^b   Chang, Chih Hsiang ^b   Ho, Feng Ming ^d,e   Liang, Yu Chih ^f  

^a TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c YUANPEI UNIVERSITY   (Taiwan)

^d TAO YUAN GENERAL HOSPITAL   (Taiwan)

^e CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cantharidin; Hyperbaric oxygen; Liposome; Octreotide; Toxicity

Indexed keywords

CANTHARIDIN; LIPOSOME; OCTREOTIDE; PEGYLATED LIPOSOMAL CANTHARIDIN; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER MODEL; CELL CULTURE; CELL DEATH; CELL STRAIN MCF 7; CONTROLLED STUDY; CULTURE MEDIUM; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG LABELING; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENCAPSULATION; FEMALE; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN; MOUSE; NEOPLASM; NONHUMAN; NUDE MOUSE;

ANIMALS; ANTINEOPLASTIC AGENTS; CANTHARIDIN; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; DRUG COMPOUNDING; ELECTROCHEMISTRY; FEMALE; HUMANS; HYPERBARIC OXYGENATION; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, NUDE; OCTREOTIDE; PARTICLE SIZE; TETRAZOLIUM SALTS; THIAZOLES;

MUS; MUS MUSCULUS;

EID: 50249090433     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.06.084     Document Type: Article

References (28)

1. Arndt D., Zeisig R., Bechtel D., and Fichtner I. Liposomal bleomycin: increased therapeutic activity and decreased pulmonary toxicity in mice. Drug Deliv. 8 (2001) 1-7
2. Chen Y.N., Chen J.C., Yin S.C., Wang G.S., Tsauer W., and Hsu S.F. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Int. J. Cancer 100 (2002) 158-165
3. Chen Y.N., Cheng C.C., Chen J.C., Tsauer W., and Hsu S.L. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells. Br. J. Pharmacol. 140 (2003) 461-470
4. Chen Y.J., Shieh C.J., Tsai T.H., Kuo C.D., Ho L.T., Liue T.Y., and Liao H.F. Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells. Anticancer Drugs 16 (2005) 293-299
5. Daruwalla J., and Christophi C. Hyperbaric oxygen therapy for malignancy: a review. World J. Surg. 30 (2006) 2112-2131
6. Efferth T., Rauh R., Kahl S., Tomicic M., Böchzelt H., Tome M.E., Briehl M.M., Bauer R., and Kaina B. Molecular modes of action of cantharidin in tumor cells. Biochem. Pharmacol. 69 (2005) 811-818
7. Gabizon A.A., Tzemach D., Horowitz A.T., Shmeeda H., Yeh J., and Zalipsky S. Reduced toxicity and superior therapeutic activity of a mitomycin clipid-based prodrug incorporated in pegylated liposomes. Clin. Cancer Res. 12 (2006) 1913-1920
8. Graziano M.J., Pessah I.N., Matsuzawa M., and Casida J.E. Partial characterization of specific cantharidin binding sites in mouse tissue. Mol. Pharmacol. 33 (1988) 706-712
9. Huang C.M., Wu Y.T., and Chen S.T. Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis. Chem. Biol. 7 (2000) 453-461
10. Huh J.E., Kang K.S., Chae C., Kim H.M., Ahn K.S., and Kim S.H. Roles of p38 and JNK mitogen-activated protein kinase pathways during cantharidin-induced apoptosis in U937 cells. Biochem. Pharmacol. 67 (2004) 1811-1818
11. Karras D.J., Farrell S.E., Harrigan R.A., Henretig F.M., and Gealt L. Poisoning from "Spanish fly" (cantharidin). Am. J. Emerg. Med. 14 (1996) 478-483
12. Kawamura N., and Casida J.E. Novel synthesis of convulsants with a unique ring system: dihydro-1,4-ethano-1H,3H-thieno[3,4-c]thiophene-3,6(4H)-dione. Chem. Res. Toxicol. 3 (1990) 453-457
13. Kok S.H., Chui C.H., Lam W.S., Chen J., Lau F.Y., Cheng G.Y., Wong R.S., Lai P.P., Leung T.W., Tang J.C., and Chan A.S. Apoptotic activity of a novel synthetic cantharidin analogue on hepatoma cell lines. Int. J. Mol. Med. 17 (2006) 945-949
14. Kok S.H., Chui C.H., Lam W.S., Chen J., Tang J.C., Lau F.Y., Cheng G.Y., Wong R.S., and Chan A.S. Induction of apoptosis on carcinoma cells by two synthetic cantharidin analogues. Int. J. Mol. Med. 17 (2006) 151-157 chance 2006a and b in the text
15. 3H] endothelial thioanhydride binding site. Biochem. Pharmacol. 46 (1993) 1435-1443
16. Liu X.H., Blazsek I., Comisso M., Legras S., Marion S., Quittet P., Anjo A., Wang G.S., and Misset J.L. Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells. Eur. J. Cancer 31A (1995) 953-963
17. Matsuzawa M., Graziano M., and Casida J. Endothal and cantharidin analogues: relation of structure to herbicidal activity and mammalian toxicity. J. Agric. Food Chem. 35 (1987) 823-829
18. McCluskey A., Ackland S.P., Bowyer M.C., Baldwin M.L., Garner J., Walkom C.C., and Sakoff J.A. Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines. Bioorgan. Chem. 31 (2003) 68-79
19. McCuskey A., Keane M.A., Mudgee L.M., Sim A.T., Sakoff J., and Quinn R.J. Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?. Eur. J. Med. Chem. 35 (2000) 957-964
20. Moed L., Shwayder T.A., and Chang M.W. Cantharidin revisited: a blistering defense of an ancient medicine. Arch. Dermatol. 137 (2001) 1357-1360
21. Nobs L., Buchegger F., Gurny R., and Allemann E. Current methods for attaching targeting ligands to liposomes and nanoparticles. J. Pharm. Sci. 93 (2004) 1980-1992
22. Oaks W.W., Ditunno J.F., Magnani T., Levy H.A., and Millsl C. Cantharidin poisoning. Arch. Int. Med. 105 (1960) 574-582
23. Rauh R., Kahl S., Boechzelt H., Bauer R., Kaina B., and Efferth T. Molecular biology of cantharidin in cancer cells. Chin. Med. 2 (2007) 8-16
24. Sakoff J.A., Ackland S.P., Baldwin M.L., Keane M.A., and McCluskey A. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues. Invest. New Drugs 20 (2002) 1-11
25. Sakoff J.A., Howitt I.J., Ackland S.P., and McCluskey A. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition. Cancer Chemother. Pharmacol. 53 (2004) 225-232
26. Shan H.B., Cai Y.C., Liu Y., Zeng W.N., Chen H.X., Fan B.T., Liu X.H., Xu Z.L., Wang B., and Xian L.J. Cytotoxicity of cantharidin analogues targeting protein phosphatase 2A. Anticancer Drugs 17 (2006) 905-911
27. Wang G.S. Medical use of Mylabris in ancient China and recent studies. J. Ethnopharmacol. 26 (1989) 147-162
28. Wang C.C., Wu C.H., Hsieh K.J., Yen K.Y., and Yang L.L. Cytotoxic effects of cantharidin on growth of normal and carcinoma cells. Toxicology 147 (2000) 77-87